Thor Halfdanarson, Vice President of the North American Neuroendocrine Tumor Society, shared on X:
“What a time to be alive! Fantastic review of therapy options for NSCLC by Rami Manochakian. This and so much more at the Mayo Hematology and Oncology Board Review and Practice Update. Don’t miss it in the future. All your review needs in heme/onc covered.”
